Close Menu

biomarker discovery

Bioinformatics firm Berg is combining multi-omics data from the Department of Defense's Center for Prostate Disease Research in search of biomarkers.

CSO Phil Stephens said the firm is finding specific genomic alterations that appear to affect sensitivity to immunotherapies, as it also advances overall mutation burden testing.

A series of new studies contain clues to predicting heart disease in healthy individuals and future problems in those already treated for cardiovascular conditions.